• Align technology: Piper Sandler & Co maintains its overweight recommendation with a price target reduced from USD 415 to USD 370.
  • Allstate: Morningstar downgrades to hold from buy with a target price of USD 122.
  • Apple inc: Haitong International Research Ltd maintains its neutral recommendation with a target price of USD 186.
  • Copart: Baptista Research maintains its underperform recommendation with a target price of USD 39.10.
  • Crowdstrike: DZ Bank AG Research initiates a buy recommendation with a target price of USD 215.
  • Dexcom: Morningstar upgrades to hold from sell with a target price of USD 92.
  • Expedia: Baptista Research initiates a buy recommendation with a target price of USD 128.70.
  • Fortinet: BMO Capital Markets maintains its market perform recommendation with a price target reduced from USD 72 to USD 64.
  • Globalfoundries: Baptista Research upgrades to buy from hold with a price target raised from USD 72.10 to USD 79.20.
  • M&g plc: BNP Paribas Exane upgrades to outperform from neutral with a price target raised from GBP 2.10 to GBP 2.30.
  • Ocado group plc: HSBC downgrades its recommendation to reduce and lowers the target price from GBP 5.45 to GBP 4.15.
  • Palo alto networ: BMO Capital Markets maintains its outperform rating and raises the target price from USD 275 to USD 300.
  • Phoenix group ho: BNP Paribas Exane upgrades to outperform from neutral with a price target reduced from GBX 640 to GBX 560.
  • Prologis: Morningstar upgrades to buy from hold with a target price of USD 124.
  • S&p global: Baptista Research maintains its hold recommendation with a target price of USD 402.90.
  • Spirax-sarco eng: Numis upgrades to add from buy with a price target reduced from GBX 11000 to GBX 9500.
  • St. james's place: HSBC downgrades to hold from buy with a price target reduced from GBP 11.25 to GBP 7.50.
  • Synopsys inc: Deutsche Bank maintains its buy recommendation and raises the target price from USD 465 to USD 585.
  • Zscaler: BMO Capital Markets maintains its outperform rating and raises the target price from USD 180 to USD 195.